- Home
- DOCU vs WST Comparison
DOCU vs WST Comparison
Compare DOCU & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCU
- WST
- Stock Information
- Founded
- DOCU 2003
- WST 1923
- Country
- DOCU United States
- WST United States
- Employees
- DOCU 6838
- WST N/A
- Industry
- DOCU EDP Services
- WST Medical/Dental Instruments
- Sector
- DOCU Technology
- WST Health Care
- Exchange
- DOCU Nasdaq
- WST Nasdaq
- Market Cap
- DOCU 16.4B
- WST 15.6B
- IPO Year
- DOCU 2018
- WST N/A
- Fundamental
- Price
- DOCU $80.33
- WST $279.94
- Analyst Decision
- DOCU Hold
- WST Buy
- Analyst Count
- DOCU 15
- WST 7
- Target Price
- DOCU $91.42
- WST $331.67
- AVG Volume (30 Days)
- DOCU 2.4M
- WST 772.3K
- Earning Date
- DOCU 09-04-2025
- WST 07-24-2025
- Dividend Yield
- DOCU N/A
- WST 0.30%
- EPS Growth
- DOCU 922.41
- WST N/A
- EPS
- DOCU 5.25
- WST 6.68
- Revenue
- DOCU $3,030,753,000.00
- WST $2,960,200,000.00
- Revenue This Year
- DOCU $8.27
- WST $3.38
- Revenue Next Year
- DOCU $6.55
- WST $5.82
- P/E Ratio
- DOCU $15.31
- WST $41.75
- Revenue Growth
- DOCU 7.85
- WST 2.90
- 52 Week Low
- DOCU $48.80
- WST $187.43
- 52 Week High
- DOCU $107.86
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- DOCU 54.70
- WST 79.28
- Support Level
- DOCU $75.40
- WST $206.80
- Resistance Level
- DOCU $77.58
- WST $226.03
- Average True Range (ATR)
- DOCU 2.18
- WST 7.43
- MACD
- DOCU 0.72
- WST 3.38
- Stochastic Oscillator
- DOCU 83.43
- WST 87.29
About DOCU DocuSign Inc.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.